Search Results 21-30 of 13142 for Tyrosine
This medicine is also used to treat metastatic NSCLC in patients who have already received EGFR tyrosine kinase inhibitor (TKI) treatment, which did not work.
... tyrosine kinase. Medications called tyrosine kinase inhibitors (TKIs) are first-line treatments. Each medication has its own side effects, such as swelling ...
Dermatomyositis is a condition that affects the muscles and skin. This medicine is a Janus kinase (JAK) and tyrosine kinase 2 inhibitor that works on the immune ...
It is also given to adults and children with Ph+ CML in chronic phase (CP) or accelerated phase (AP) who have taken other medicines (eg, imatinib, tyrosine- ...
Bruton tyrosine kinase inhibitors for multiple sclerosis. Nature Reviews Neurology. 2023; doi:10.1038/s41582-023-00800-7. Pediatric MS. National Multiple ...
The purpose of this study is to prospectively define the incidence of new and/or worsening hypertension in patients with B-cell malignancies on Bruton Tyrosine ...
... Tyrosine Kinase) Inhibitors. Circ Res. 2021 Jun 11; 128 (12):1973-1987 Epub 2021 June 10. View PubMed; Fleming MR, Brown MR, Kronengold J, Zhang Y, Jenkins DP ...
... tyrosine kinase inhibitor (cBTKi). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...
Testing whether metazoan tyrosine loss was driven by selection against promiscuous phosphorylation. Mol Biol Evol. 2015 Jan; 32 (1):144-52 Epub 2014 Oct 13
This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring salvage therapy as assessed ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.